News
geographic atrophy
PRIMA implant offers hope to patients with geogrpahic atrophy
The PRIMA implant has currently only gained approval for use in the European Union but it has received Breakthrough Device and Humanitarian Use Device designations from the Food and Drug Administra...
geographic atrophy
Positive clinical trial results of wireless retinal implant
Results of a clinical trial testing a new wireless retinal implant were recently published in the New England Journal of Medicine.
age related macular degeneration
Phase 2b clinical trials set for potential AMD treatment
More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...
AMD
FDA approves Izervay for treatment of geographic atrophy
The Food and Drug Administration (FDA) recently announced their approval of Izervay for treatment of geographic atrophy (GA) secondary to age-related macular degeneration.
age-related macular degeneration
FDA approves first drug to treat geographic atrophy
Geographic atrophy typically affects people over the age of 50 and is one of the main causes of vision loss in the United States.
AMD
AI algorithm may be a helpful tool for determining progression of AMD
Artificial intelligence may be the key in helping doctors determine which patients with intermediate AMD are at a high risk of the disease progressing to geographic atrophy.
age-related macular degeneration
What else can I do?
Among the many rewards of formulating premium macular degeneration eye vitamins is the daily positive feedback I receive from my own patients. And the vast majority of them have enjoyed stability i...